PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: TransEnterix, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

TransEnterix Announces First Human Cases Using its Advanced Energy Device - Flexible ligating shears designed for full 360 degree articulation with SPIDER® Surgical System - TransEnterix.com
TransEnterix Announces First Human Cases Using its Advanced Energy Device

 

NewswireToday - /newswire/ - Research Triangle Park, NC, United States, 2014/04/16 - Flexible ligating shears designed for full 360 degree articulation with SPIDER® Surgical System - TransEnterix.com. NYSE: TRXC

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

TransEnterix, Inc., a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery, today announced the first human cases performed using its recently launched fully flexible advanced energy device.

The Flex Ligating Shears, which has received 510(k) clearance from the U.S. Food and Drug Administration, is designed to deliver full flexibility to the surgeon while offering ligation and division with direct thermal energy in various laparoscopic surgical procedures.

“TransEnterix now offers the only advanced energy device that completely articulates 360 degrees to provide optimal access to surgeons within the operating field, while competing technologies offer limited or no articulation,” said Todd M. Pope, President and CEO of TransEnterix. “With the SPIDER Flex Ligating Shears, we can offer surgeons the ability to attain precise angles when cutting and dividing tissue in a laparoscopic procedure.”

Advanced energy devices represent one of the most versatile and critical tools for surgeons in minimally invasive surgery. These devices deliver controlled energy to effectively ligate and divide tissue while greatly limiting bleeding in the operative field and minimizing thermal injury to surrounding structures.

Dr. Andrew Hargroder, a general and bariatric surgeon in Baton Rouge, Louisiana, was the first surgeon to utilize the new device for sleeve gastrectomy procedures. “The SPIDER Flex Ligating Shears offered me a fast and simple way to cut and seal tissue,” said Dr. Hargroder. “The device created no plume to impair visualization, sealed tissue extremely well, and appeared to minimize thermal spread. With 360 degrees of angulation, this device reaches areas where rigid instruments may have difficulty.”

TransEnterix’s advanced energy device has been created for surgeons to use with the company’s existing SPIDER Surgical System. The company intends to offer a similar device in the future for its SurgiBotTM system, a new patient-side robotic surgery system currently under development.

About TransEnterix

TransEnterix (transenterix.com) is a medical device company that is pioneering the use of flexible instruments and robotics to improve minimally invasive surgery. The company is focused on the development and commercialization of the SurgiBot™ system, a minimally invasive surgical robotic system that allows the surgeon to be patient-side within the sterile field.

Forward Looking Statements
This press release includes statements relating to our advanced energy device and SurgiBot system, as well as our current regulatory and commercialization plans for the system. These statements and other statements regarding our future plans and goals constitute “forward looking statements” within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control, and which may cause results to differ materially from expectations. Factors that could cause our results to differ materially from those described include but are not limited to: the pace of adoption of our product technology by surgeons, including the Flex Ligating Shears Advanced Energy Device; whether the SPIDER Flex Ligating Shears can offer surgeons the ability to attain precise angles when cutting and dividing tissue in a laparoscopic procedure; the success and market opportunity of our continuing and new product development efforts, including the SurgiBot system; the effect on our business of existing and new regulatory requirements; and other economic and competitive factors. For a discussion of the most significant risks and uncertainties associated with TransEnterix's business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended Dec. 31, 2013; and subsequent SEC reports. You are cautioned not to place undue reliance on these forward-looking statements, which are based on our expectations as of the date of this press release and speak only as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

Investor Contact: Mark Klausner, Westwicke Partners
P: 443-213-0501 - E: transenterix[.]westwicke.com.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: TransEnterix, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


TransEnterix Announces First Human Cases Using its Advanced Energy Device

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

TransEnterix |
Publisher Contact: Sarah Klein - TransEnterix.com 
336-971-0909 sklein[.]transenterix.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any TransEnterix, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From TransEnterix, Inc. / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

Intubation Market Significant Profits Estimated to be Generated by 2025 Says Persistence Market Research
PMR Releases Report for Next Generation IV Infusion Pumps Market Impact of Existing and Emerging Market 2017-2025
Medical Tapes Market to Reach US$ 2Bn by 2024 Reports PMR
Global Pyrogen Testing Market Value Expected to Increase to US$ 1.37 Billion by 2024 Says PMR
Huber Needles Market Expected to Reach US$ 55M by 2024 According to PMR
ZOLL Technologies for Improving CPR Quality to be Showcased at NTI 2017
ConfirmMDx Improves Prostate Cancer Diagnosis in African American Men
Biomarker-based Technologies to Disrupt Conventional Diagnosis in Diabetes Management across the Globe Finds Frost & Sullivan
Agfa Specialty Products Announces the Launch of UNIQOAT
Sparta Releases Stratas 3.0 and TrackWise Intake
GE Healthcare Signs Agreement with HealthTrust to Supply Radiopharmaceuticals
GE Introduces CardioGraphe - The World’s First Dedicated Cardiovascular CT System
Frost & Sullivan Lauds ClearFlow’s ACT® Technology as a Transformational Force in Post-operative Cardiothoracic Surgery Protocols
ZOLL Receives Health Canada Approval for Two New Models of AEDS
ZOLL Hospital Wearable Defibrillator Receives Premarket Approval from the FDA

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  MagLar, Inc.

Visit  Persistence Market Research (P) Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)